|
| [November 27, 2012] |
 |
Nevirapine Examined in New In-Demand Genericsweb Patent Search Report Now Available at MarketPublishers.com
LONDON --(Business Wire)--
Previously popular under the codename BI-RG-587, Nevirapine is
manufactured by Boehringer Ingelheim under the trade name Viramune, or
Viramune XR. Nevirapine belongs to a class of drugs known
as non-nucleoside reverse transcriptase inhibitors (NNRTIs). Nevirapine
is helpful in treating HIV-1 infection and AIDS, in combinations of
three or more antiretrovirals such as Lamivudine, Stavudine, Zidovudine
and Tenofovir.
Nevirapine became the first NNRTI that was approved by the US Food and
Drug Administration (FDA) - in June 1996 for adults and in September
1998 for children. In the EU the anti-HIV drug was licensed in February
1998.
New report "Nevirapine
- Comprehensive patent search" elaborated by Genericsweb is a
monthly updated, professional patent search, which not only identifies
relevant patents, but presents categorization and interpretation, all
delivered by a convenient online interface. In particular, the pipeline
developer report features:
-
comprehensive patent searching, offering data for the world's key
territories;
-
patents covering molecule, formulation, process, use, combination and
assay techniques;
-
patent identification, categorization and interpretation;
-
-
filtration of patents not relevant to generic development;
-
relevant changes to patent families, statuses, and litigation;
-
hyperlinks to crucial patent documents and national registers.
Patent Categories Mentioned Include:
-
molecular form;
-
active ingredient preparation;
-
formulations & methods thereof;
-
related medical use & administration;
-
active ingredient combinations;
-
analytical methods.
Report Details:
Title: Nevirapine - Comprehensive patent search
Published: November, 2012
Price: US$ 7,200.00
http://marketpublishers.com/report/pharmaceuticals/drugs/nevirapine-comprehensive-patent-search.html
Other Drugs Comprehensive Patent Search Reports by Genericsweb are
Also Available:
More new pipeline reports by Genericsweb can be found at http://marketpublishers.com/members/genericsweb/info.html
[ Back To HTML5's Homepage ]
|